RhoVac
is a Sweden-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer... Read moreRhoVac
is a Sweden-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer... Read more
News
Dec 05, 2022
Cision
Press Release: RhoVac : RhoVac AB conducts conditional reverse takeover of Chosa ApS
Oct 18, 2022
FinanzNachrichten
RhoVac: Rhovac board member resigns due to health reasons
Aug 09, 2022
Cision
Press Release: RhoVac : The board decides on first partial repayment of convertible loan
Jul 15, 2022
Cision
Press Release: RhoVac : RhoVac's CEO, Anders Mnsson, has tendered his resignation
Jul 15, 2022
rhovac
Press Release: RhoVac : RhoVac's CEO, Anders Månsson, has tendered his resignation
Jul 13, 2022
FirstWord Pharma
RhoVac: RhoVac terminates its stock liquidity provision service and announces the last day for trading in the convertible
Jun 30, 2022
Cision
Press Release: RhoVac : RhoVac provides a status update and investigates a potentially accelerated repayment of the convertible loan
Jun 15, 2022
MarketScreener
RhoVac: RhoVac : Anmlningssedel - Konvertibler RhoVac ENG PDF
May 31, 2022
Endpoints News
RhoVac: Swedish biotech crumbles in face of PhII failure of prostate cancer vaccine
May 31, 2022
PharmaLive
RhoVac: Once-hopeful prostate cancer drug fails Phase II test
RhoVac Competitors
1
2
3
4
5
6
7
8